Evidence map›Paper›PMID 32226272›Full record

ArticleDrugs & therapy perspectives : for rational drug selection and use2019

Assessing the impact of structured education on the knowledge of hospital pharmacists about adverse drug reactions and reporting methods in Saudi Arabia: an open-label randomised controlled trial.

Ejaz Cheema, Abdulmohsin Abdulaziz Almualem, Abdulmohsen Talal Basudan, AbdulAziz Khalid Salamatullah, Sohaib Omar Radhwi, Ammar Soliman Alsehli

Open access · bronzeAbstract read
In one paragraph

Article in Drugs & therapy perspectives : for rational drug selection and use, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ejaz Cheema1School of pharmacy, University of Birmingham, Edgbaston, Birmingham, B15 2TT UK.ORCID 0000-0002-8538-7392
Abdulmohsin Abdulaziz Almualem2College of pharmacy, Umm-al-Qura University, Makkah, Saudi Arabia.
Abdulmohsen Talal Basudan2College of pharmacy, Umm-al-Qura University, Makkah, Saudi Arabia.
AbdulAziz Khalid Salamatullah2College of pharmacy, Umm-al-Qura University, Makkah, Saudi Arabia.
Sohaib Omar Radhwi2College of pharmacy, Umm-al-Qura University, Makkah, Saudi Arabia.
Ammar Soliman Alsehli2College of pharmacy, Umm-al-Qura University, Makkah, Saudi Arabia.
Umm al-Qura University · SAUniversity of Birmingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPharmacists have limited knowledge about adverse drug reactions (ADRs) in Saudi Arabia.

objectiveThe aim of this study was to assess the impact of educational intervention on the knowledge of hospital pharmacists about ADRs.

methodsThis was a 3-month randomized controlled trial conducted in Saudi Arabia between January 2018 and March 2018. Participants in both groups were required to complete an online questionnaire at baseline and at 12-week follow-up. Participants in the intervention group received a structured information sheet about ADRs 2 weeks after the first assessment. The main outcome measure was difference in mean knowledge score about ADRs.

main outcome measureDifference in mean knowledge score about ADRs.

resultsA total of 46 participants were included in the study. At the 12-week follow-up, there was a significant improvement in the mean knowledge score (± standard deviation) of intervention participants from 7.67 (± 2.1) at baseline to 11.22 (± 0.4) (95% CI -4.5 to -2.5;

conclusionADR-specific education was associated with a significant improvement in the knowledge and understanding of pharmacists about ADRs and their methods of reporting.

Identifiers

PMID32226272
PMCPMC7100567
OpenAlexW2923377811

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.